Jump to ContentJump to Main Navigation
Venous Thromboembolism in Advanced DiseaseA clinical guide$
Users without a subscription are not able to see the full content.

Simon I R Noble, Miriam J Johnson, and Agnes Y Y Lee

Print publication date: 2008

Print ISBN-13: 9780199232048

Published to Oxford Scholarship Online: November 2011

DOI: 10.1093/acprof:oso/9780199232048.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 22 September 2021

Primary thromboprophylaxis in the advanced cancer patient

Primary thromboprophylaxis in the advanced cancer patient

(p.111) Chapter 7 Primary thromboprophylaxis in the advanced cancer patient
Venous Thromboembolism in Advanced Disease

Simon I.R. Noble

Oxford University Press

This chapter reviews the current published evidence available that may guide the clinician in the appropriate use of primary thromboprophylaxis and in the application of this evidence in the care of advanced cancer patients. It provides recommendations for the prevention of venous thromboembolism (VTE) in the real world palliative care setting and discusses some relevant clinical cases. It suggests that thromboprophylaxis is inappropriate in the terminal phases since symptoms attributable to VTE can be managed with end-of-life drugs.

Keywords:   primary thromboprophylaxis, advanced cancer, VTE, palliative care, end-of-life drugs

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .